NAD+ IV Therapy: The Science Behind Cellular Energy and Longevity
2026-08-11 · 6 min read

NAD+ sits at the centre of how cells make energy and repair DNA. Here is what the science supports, and what it does not.
NAD+ has moved from biochemistry textbooks to wellness marketing with unusual speed, and the claims have outrun the evidence in places. What follows is a measured account of what nicotinamide adenine dinucleotide does, why intravenous delivery is used, and what patients can reasonably expect.
What NAD+ actually does
Every cell in your body uses NAD+ to convert food into usable energy. It is the shuttle that carries electrons through the reactions inside mitochondria that ultimately produce ATP. Without adequate NAD+, energy production slows regardless of how well you eat or sleep.
Its second role is arguably more interesting. NAD+ is the required fuel for two families of repair enzymes: sirtuins, which regulate cellular stress responses and metabolic health, and PARPs, which repair damaged DNA. Both consume NAD+ as they work. When supply falls, repair capacity falls with it.
Why levels decline
Measurements suggest tissue NAD+ concentrations fall substantially between early adulthood and later life. Two things drive this: reduced synthesis, and increased consumption. Chronic inflammation, accumulated DNA damage, poor sleep, alcohol and sustained metabolic stress all raise the demand side, which is why two people of the same age can differ considerably.
The consequence is a loop. Lower NAD+ means less efficient energy production and slower repair, which produces more cellular damage, which consumes more NAD+.
Why intravenous delivery
Oral NAD+ is largely broken down before absorption; the molecule is too large and too fragile to survive digestion intact. Precursors such as NMN and NR are more viable orally and have a legitimate role, but conversion to usable NAD+ is indirect and variable between individuals.
Intravenous administration places NAD+ directly into circulation. The trade-off is comfort: infused too quickly, NAD+ produces chest tightness, nausea and flushing. This is why sessions are slow — commonly two to four hours — with the rate adjusted continuously. Any clinic offering a rapid NAD+ drip is prioritising throughput over the patient.
What patients report
The most consistent feedback concerns mental clarity and stable daytime energy, often noticed within a few days of the first sessions. Sleep quality frequently improves. Patients recovering from illness or heavy travel loads tend to report the largest change, presumably because they start from a more depleted baseline.
Longevity claims require more caution. NAD+ supports pathways associated with healthy ageing, but no infusion protocol has been shown to extend human lifespan. We present it as one component of a longevity program, alongside metabolic health, sleep, resistance training and antioxidant support — not as a substitute for any of them.
How a program is structured
A typical initial course runs several sessions across one to two weeks, followed by maintenance at monthly or quarterly intervals depending on response and goals. Dosing starts conservatively and increases only if the first session is well tolerated. We check kidney and liver function beforehand and review markers as the program continues.
If persistent fatigue is your main concern, investigation should come before infusion — thyroid function, iron studies, sleep quality and inflammatory markers all deserve checking first. Message our team on WhatsApp and we will tell you what is worth testing before you spend anything on treatment.
Reviewed by Bangkok Stem Cell Center Medical Team | Last updated: August 2026
What Is MSC Therapy? A Complete Patient Guide
Mesenchymal cells are the body's repair coordinators. Here is what they actually do, how a program is structured, and what a patient should expect week by week.
Exosome Therapy vs Cellular Therapy: Understanding the Difference
One sends the instructions, the other sends the factory. Understanding that distinction makes choosing between exosomes and cellular therapy far simpler.

